Keqing Shi
- Hepatology top 0.5%
- Liver Disease and Transplantation 29
- Hepatitis C virus research 17
- Cancer Research top 2%
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 17
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 61
- Hepatitis B Virus Studies 23
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 13
- Molecular Biology top 5%
-
- Pancreatitis Pathology and Treatment 14
- Co-authors
- Ming‐Hua ZhengYongping ChenWen‐Yue LiuYuanjin ZhaoMartin BraddockGui‐Qi ZhuZhuo LinYunru Yu
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Keqing Shi
201 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Hepatology 1.6k
- Cancer Research 888
- Epidemiology 1.9k
- Oncology 585
- Molecular Biology 1.4k
Countries citing papers authored by Keqing Shi
This map shows the geographic impact of Keqing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keqing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keqing Shi more than expected).
Fields of papers citing papers by Keqing Shi
This network shows the impact of papers produced by Keqing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keqing Shi. The network helps show where Keqing Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keqing Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 36 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 21 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 16 | |
| 16 | 2019 | 33 | |
| 17 | Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionbreakdown → | 2018 | 349 |
| 18 | 2015 | 17 | |
| 19 | 2015 | 22 | |
| 20 | 2015 | 17 |
About Keqing Shi
Keqing Shi is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 209 papers that have together received 5.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (61 papers), Liver Disease and Transplantation (29 papers), Hepatitis B Virus Studies (23 papers), MicroRNA in disease regulation (18 papers), Hepatitis C virus research (17 papers), Cancer-related molecular mechanisms research (17 papers), Pancreatitis Pathology and Treatment (14 papers) and Pancreatic and Hepatic Oncology Research (13 papers). The work is most often cited by research in Hepatology (1.6k citations), Cancer Research (888 citations) and Epidemiology (1.9k citations). Keqing Shi has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Ming‐Hua Zheng, Yongping Chen, Wen‐Yue Liu, Yuanjin Zhao, Martin Braddock, Gui‐Qi Zhu, Zhuo Lin, Yunru Yu, Yu‐Chen Fan and Yong‐Ping Chen. Their work appears in journals such as Science, Nucleic Acids Research and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.